Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG

Neil T Srinivasan1, Kiran H Patel1, Kashif Qamar1

  • 1From the Department of Cardiac Electrophysiology, The Barts Heart Center, St Bartholomew's Hospital, London, United Kingdom (N.T.S., M.B., R.P., P.M.E., P.D.L.); Institute of Cardiovascular Science, University College London, United Kingdom (N.T.S., K.H.P., K.Q., A.T., P.M.E., P.D.L.); and Department of Cardiology, St George's Hospital London, United Kingdom (M.T.-E.).

Insights

Hypertrophic cardiomyopathy (HCM) patients frequently fail subcutaneous implantable cardioverter-defibrillator (S-ICD) screening due to ECG features. Optimizing S-ICD screening algorithms is crucial for high-risk HCM patients.

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • Hypertrophic cardiomyopathy (HCM) presents unique electrocardiogram (ECG) challenges for subcutaneous implantable cardioverter-defibrillator (S-ICD) screening.
  • Investigating S-ICD screening failures in HCM patients is essential for improving device eligibility.

Purpose of the Study:

  • To identify the causes of S-ICD screening failure in hypertrophic cardiomyopathy patients at rest and during exercise.
  • To inform the development of optimized S-ICD ECG vector selection and sensing algorithms.

Main Methods:

  • One hundred thirty-one HCM patients with sudden cardiac death risk factors underwent S-ICD ECG screening.
  • Screening was performed in supine and standing positions, with and without exercise.
  • Statistical analysis identified factors associated with screening failure, including R:T wave ratio and European Society of Cardiology risk score.

Main Results:

  • 38% of HCM patients failed S-ICD screening across all lead vectors.
  • Screening failures occurred in supine (66%), standing (24%), and exercise (10%) positions.
  • Increased R:T wave ratio was associated with screening failure (OR 4.0), while a low R/T ratio in lead aVF and older age were associated with reduced failure.

Conclusions:

  • HCM patients exhibit a high rate of S-ICD screening failure, primarily linked to ECG R:T ratios.
  • Higher European Society of Cardiology risk scores correlate with increased screening failure rates.
  • Sensing algorithm optimization is necessary to enable S-ICD implantation in high-risk HCM patients.
Abstract

Related Concept Videos

Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...